Containment solutions
as individual as your requirements
Containment plays a critical role in the safe handling of a highly potent active pharmaceutical ingredient (HPAPI). It protects operators, preserves product integrity, and ensures compliance with regulatory requirements throughout the entire production process.
Integrated containment solutions for pharmaceutical production
Handling HPAPIs requires more than just standard safety measures. As a global leader in high-containment pharma technologies, Glatt offers integrated containment solutions that cover the entire production cycle – from laboratory and pilot plants to commercial production. Our containment concepts are precisely tailored to your OEB levels, process steps, and plant layouts, enabling safe, reproducible, and compliant pharmaceutical production.
Lab containment technologies
Maximum flexibility, minimal footprint
Our economical containment solution for laboratories offers maximum process flexibility. With the WIBObarrier® system from Weiss Pharmatechnik, it saves a significant amount of space and is extremely cost-effective across the entire process chain – from weighing, granulation, sieving and drying right through to mixing, pelletizing and coating.
For efficient cleaning, the processing unit can be removed from the technical module. This ensures that the technical module is not contaminated and makes the cleaning of the processing unit simple.
As a true all‑rounder, it can be integrated into all process options and pharma containment solutions. In addition, it can be adapted to changing GMP requirements to reliably protect products, personnel and the environment.
Containment technologies for the laboratory
One solution – various opportunities.
Total containment
Safe shielding across the entire production line
Glatt’s total containment approach integrates equipment, interfaces and handling systems into a closed, coordinated safety concept, enabling reliable operator protection, product integrity and regulatory compliance across the complete processing line. With patented technologies and decades of containment expertise, Glatt sets the benchmark for total containment solutions in pharmaceutical manufacturing.
Pressure-shock-resistant systems for high-containment pharma
Clean-in-Place – an essential component of total containment
TKS containment valve – split butterfly valve for critical transfer points
The TKS containment valve is a key element of Glatt’s containment strategy, developed for contamination-free product transfer at critical interfaces. Based on a patented design with two identical seals, it creates a closed transfer connection between vessels and equipment, enabling safe handling of highly active substances with very low emission levels – even during repeated docking.
The TKS split butterfly valve has proven itself in long-term operation at leading pharmaceutical manufacturers worldwide and combines maximum safety with operational efficiency and a life-cycle-oriented design.
TKS Containment Valve System
Maximum safety & minimal maintenance time.
Learn more about the TKS high-performance split butterfly valve:
Containment solutions integrated from the earliest planning stages
Our specialists support you in systematically analyzing risks within your process environment, assessing hazard potential and defining containment measures as part of a structured risk assessment. This early integration ensures safe, compliant and cost‑efficient containment concepts throughout the entire lifecycle of your pharmaceutical production.